A new role for the neuronal ubiquitin C-terminal hydrolase-LI (UCH-LI) in podocyte process formation and podocyte injury in human glomerulopathies

Journal of Pathology

Volumn 217, Issue 3, 2009, Pages 452-464

  Meyer Schwesinger, C ^a   Meyer, T N ^a   Munster S ^a   Klug, P ^a   Saleem, M ^b   Helmchen, U ^a   Stahl, R A K ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

Glomerulonephritis; PGP 9.5; Podocyte injury; Protein degradation and internalization; Ubiquitin modification; UCH L1

Indexed keywords

ALPHA ACTININ 4; NEPHRIN; UBIQUITIN; UBIQUITIN THIOLESTERASE; ACTININ; ACTN4 PROTEIN, HUMAN; MEMBRANE PROTEIN; UCHL1 PROTEIN, HUMAN;

ARTICLE; CELL DAMAGE; CELL DIFFERENTIATION; CONTROLLED STUDY; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HUMAN; HUMAN CELL; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NERVE CELL; PODOCYTE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; CASE CONTROL STUDY; CELL CULTURE; CONFOCAL MICROSCOPY; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTININ; CASE-CONTROL STUDIES; CELLS, CULTURED; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; PODOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UBIQUITIN; UBIQUITIN THIOLESTERASE;

EID: 60549084713     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2446     Document Type: Article

References (35)

1. Ahola H, Heikkila E, Astrom E, Inagaki M, Izawa I, Pavenstadt H, et al. A novel protein, densin, expressed by glomerular podocytes. J Am Soc Nephrvl 2003;14:1731-1737.
2. Asanuma K, Mundel P. The role of podocytes in glomerular pathobiology. Clin Exp Nephrvl 2003;7:255-259.
3. Putaala H, Soininen R, Kilpelainen P, Wartiovaara J, Tryggvason K. The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 2001;10:1-8.
4. Kobayashi N, Gao SY, Chen J, Saito K, Miyawaki K, Li CY, et al. Process formation of the renal glomerular podocyte: is there common molecular machinery for processes of podocytes and neurons? Anat Sci Int 2004;79:1-10.
5. Sakurai M, Ayukawa K, Setsuie R, Nishikawa K, Hara Y, Ohashi H, et al. Ubiquitin C-terminal hydrolase L1 regulates the morphology of neural progenitor cells and modulates their differ entiation. J Cell Sci 2006;119:162-171.
6. Saigoh K, Wang YL, Suh JG, Yamanishi T, Sakai Y, Kiyo sawa H, et al. Intragenic deletion in the gene encoding ubiq uitin carboxy-terminal hydrolase in gad mice. Nature Genet 1999;23:47-51.
7. Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT Jr. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 2002;111:209-218.
8. Gong B, Cao Z, Zheng P, Vitolo OV, Liu S, Staniszewski A, et al. Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 2006;126:775-788.
9. Lansbury PT Jr. Improving synaptic function in a mouse model of AD. Cell 2006;126:655-657.
10. Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, Chin LS, et al. Oxidative modifications and down-regulation of ubiq uitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J Biol Chem 2004;279:13256-13264.
11. Liu Y, Lashuel HA, Choi S, Xing X, Case A, Ni J, et al. Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line. Chem Biol 2003;10:837-846.
12. Otsuki T, Yata K, Takata-Tomokuni A, Hyodoh F, Miura Y, Sakaguchi H, et al. Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C- terminal hydrolase 1 (UCHL-1) in human myeloma cells. Br J Haematol 2004;127:292-298.
13. Hibi K, Liu Q, Beaudry GA, Madden SL, Westra WH, Wehage SL, et al. Serial analysis of gene expression in non-small cell lung cancer. Cancer Res 1998;58:5690-5694.
14. Debigare R, Price SR. Proteolysis, the ubiquitin-proteasome system, and renal diseases. Am J Physiol Renal Physiol 2003;285:F1-F8.
15. Ciechanover A, Orian A, Schwartz AL. The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications. J Cell Biochem 2000;77:40-51.
16. Wilkinson KD. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J 1997;11:1245-1256.
17. Wilkinson KD, Lee KM, Deshpande S, Duerksen-Hughes P, Boss JM, Pohl J. The neuron-specific protein PGP 9.5 is a ubiq uitin carboxyl-terminal hydrolase. Science 1989;246:670-673.
18. Osaka H, Wang YL, Takada K, Takizawa S, Setsuie R, Li H, et al. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet 2003;12:1945-1958.
19. Larsen CN, Krantz BA, Wilkinson KD. Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry 1998;37:3358-3368.
20. Wilkinson KD. Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. Semin Cell Dev Biol 2000;11:141-148.
21. Shirato I, Asanuma K, Takeda Y, Hayashi K, Tomino Y. Protein gene product 9.5 is selectively localized in parietal epithelial cells of Bowman's capsule in the rat kidney. J Am Soc Nephrol 2000;11:2381-2386.
22. Diomedi-Camassei F, Rava L, Lerut E, Callea F, Van Damme B. Protein gene product 9.5 and ubiquitin are expressed in metabolically active epithelial cells of normal and pathologic human kidney. Nephrol Dial Transplant 2005;20:2714-2719.
23. Franch HA. Pathways of proteolysis affecting renal cell growth. Curr Opin Nephrol Hypertens 2002;11:445-450.
24. Saleem MA, O'Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T, et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 2002;13:630-638.
25. Meyer TN, Schwesinger C, Wahlefeld J, Dehde S, Kerjaschki D, Becker JU, et al. A new mouse model of immune-mediated podocyte injury. Kidney Int 2007;72:841-852.
26. Abramoff MMP, Ram SJ. Image processing with Image J. Biophotonics Int 2004;11:36-42.
27. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, et al. Positionally cloned gene for a novel glomeru lar protein - nephrin - is mutated in congenital nephrotic syn drome. Mol Cell 1998;1:575-582.
28. Kobayashi N, Mominoki K, Wakisaka H, Shimazaki Y, Matsuda S. Morphogenetic activity of extracellular matrices on cultured podocytes. Laminin accelerates podocyte process formation in vitro. Ital J Anat Embryol 2001;106:423-430.
29. Kobayashi N. Mechanism of the process formation; podocytes vs. neurons. Microsc Res Tech 2002;57:217-223.
30. Kobayashi N, Mundel P. A role of microtubules during the formation of cell processes in neuronal and non-neuronal cells. Cell Tissue Res 1998;291:163-174.
31. Kobayashi N, Reiser J, Kriz W, Kuriyama R, Mundel P. Nonuniform microtubular polarity established by CHO1/MKLP1 motor protein is necessary for process formation of podocytes. J Cell Biol 1998;143:1961-1970.
32. Schiwek D, Endlich N, Holzman L, Holthofer H, Kriz W, Endlich K. Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines. Kidney Int 2004;66:91-101.
33. Hicke L, Zanolari B, Riezman H. Cytoplasmic tail phosphorylation of the alpha-factor receptor is required for its ubiquitination and internalization. J Cell Biol 1998;141:349-358.
34. Bonifacino JS, Weissman AM. Ubiquitin and the control of protein fate in the secretory and endocytic pathways. Annu Rev Cell Dev Biol 1998;14:19-57.
35. Marchese A, Benovic JL. Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J Biol Chem 2001;276:45509-45512.